ÂÜÀòÂÒÂ×

Aris Baras is the SVP of Regeneron Genetics Center at Regeneron. Aris has over 15 years of experience in the biotech and pharmaceutical industries. Aris started their career as a consultant for Liquidia Technologies from January 2007 to December 2011 where they focused on R&D Strategy and Business Development. In August 2004, Aris started working at Duke University Medical Center as a Biomedical Research conducting research in the Haystead Lab for Pharmacology & Cancer Biology from 2011-2012, the Tedder Lab for Immunology from 2005-2006, and the Lyerly/Devi Lab for Cancer Center from 2004-2006.

Aris Baras received their BS in Biology and Economics from Duke University. Aris then went on to receive their MBA from Duke University's Fuqua School of Business with a Health Sector Management Certificate. Finally, they completed their MD at Duke University School of Medicine.

Aris Baras reports to Neil Stahl, EVP, R&D. They are on a team with Gary Herman - SVP, Early Clinical Development & Experimental Sciences, David Weinreich - SVP Global Clinical Development, and John Lin - SVP, Immuno-Oncology & Head of Bispecifics.